# Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer

> **NCT02342054** · PHASE2 · UNKNOWN · sponsor: **Hospital de Cruces** · enrollment: 49 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** MRI-TRUS fusion guided Single Frac HDR

## Key facts

- **NCT ID:** NCT02342054
- **Lead sponsor:** Hospital de Cruces
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2015-10
- **Final completion:** 2017-12
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2015-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342054, "Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02342054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*